Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Can pharmacogenomics improve malaria drug policy?

Bulletin of the World Health Organization - 1 Nov 2011

Roederer Mary W, McLeod Howard, Juliano Jonathan J

Abstract excerpt

Coordinated global efforts to prevent and control malaria have been a tour-de-force for public health, but success appears to have reached a plateau in many parts of the world. While this is a multifaceted problem, policy strategies have largely ignored genetic variations in humans as a factor that influences both selection and dosing of antimalarial drugs. This includes attempts to decrease toxicity, increase...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Public Health
Share to Africa
Share to Antimalarials

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Decision Making

Share to Global Health

Share to Health Policy

Share to Health Promotion

Share to Malaria, Falciparum

Source

Open in PubMed Open full text

Identifiers

PMID: 22084530
DOI: 10.2471/BLT.11.087320
PMCID: PMC3209725

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Can pharmacogenomics improve malaria drug policy?PMID 22084530Read ↗

An update on pharmacogenetic factors influencing the metabolism and toxicity of artemisinin-based combination therapy in the treatment of malariaSemantic proximity Read ↗

The pharmacogenetics of antimalaria artemisinin combination therapy.Semantic proximity Read ↗

Genomic Approaches to Drug Resistance in Malaria.Semantic proximity Read ↗

How can we identify parasite genes that underlie antimalarial drug resistance?Semantic proximity Read ↗

Antimalarial Drug Resistance and Novel Targets for Antimalarial Drug DiscoverySemantic proximity Read ↗

Understanding drug resistance in malaria parasites: Basic science for public healthSemantic proximity Read ↗

Genetic surveillance for monitoring the impact of drug use on Plasmodium falciparum populationsSemantic proximity Read ↗

Polymorphisms in Cytochrome P450 genes: implications for Plasmodium vivax malaria treatment in Brazil.Semantic proximity Read ↗

Expanding the Antimalarial Drug Arsenal—Now, But How?Semantic proximity Read ↗

How genomics is contributing to the fight against artemisinin-resistant malaria parasitesSemantic proximity Read ↗

The impact of phenotypic- versus target-based approaches in antimalarial drug discovery in the last two decades (2005-2025).Semantic proximity Read ↗

Plasmodium falciparum genetic factors rather than host factors are likely to drive resistance to ACT in GhanaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.